Skip to main content

Events

Featured Events

  • HALL B1 - BOOTH A10
    -

    ESCMID GLOBAL 2026

    Munich, Germany | Europe | BOOTH #A10
    Immunodiagnostics
    Luminex LTG
    Molecular diagnostics
    Find out more
    Add to Calendar
    Add to Calendar 2026-04-17T09:00:00 2026-04-21T18:00:00 ESCMID GLOBAL 2026 <div style="font-family:&apos;Segoe UI&apos;;font-size:14px;font-style:normal;font-weight:400;line-height:20px;"><h3><strong>Join us at ESCMID Global 2026 in Munich!</strong></h3><p>&nbsp;</p><p>From <strong>April 17–21, 2026</strong>, visit us at <strong>ESCMID</strong> in <strong>Munich </strong>(Hall B1, Booth A10)<strong> </strong>and discover how our cutting‑edge diagnostic solutions are advancing respiratory infection management by delivering fast, accurate and specialized results that support confident, evidence‑based clinical decision‑making.</p><p><strong>Discover more about the event and register here</strong>: <a class="OWAAutoLink" href="https://connect.diasorin.com/ESCMID2026" id="OWA69aaed29-1ab8-a591-504d-bfc5ac7e6eb0">ESCMID: Munich 2026</a></p><h4>Integrated Symposium</h4><p>Save the date for an <strong>exclusive scientific symposium </strong>on <strong>April 19</strong> bringing together international experts to explore how next‑generation immunoassays and highly accurate molecular testing are transforming respiratory diagnostics.&nbsp;</p><ul><li><strong>Date and time</strong>: 19 April, 2026, 16:15 - 17:45 CET</li><li><strong>Location</strong>: Hall A1-3 - ESCMID 2026 - Munich</li></ul><p><strong>Discover the Symposium full Agenda:</strong></p><ul><li><strong>Workflow, Performance &amp; Clinical Value of a Flexible Syndromic Respiratory Pathogen Panel </strong>(Heba Mostafa, MD, PhD, The Johns Hopkins Hospital, Baltimore, US)</li><li><strong>Optimizing Pneumonia Diagnosis with Automated Urinary Antigen Testing: CLIA Legionella &amp; Streptococcus UAT</strong> (Andrew McGlinchey, Principal Scientist Microbiology Dep, Melbourne, Australia)</li><li><strong>Modern Diagnostics for a Silent Disease: The Role of IGRA in Latent TB Care in Pediatric Population</strong> (James Gaensbauer, MD, MScPH. Director of Education, Mayo Clinic Center for Tuberculosis, Rochester, US)</li><li><strong>Performance Assessment of a Second-Generation IGRA-TB Assay: Advancing Laboratory Automation in Tuberculosis Diagnostics</strong> (Cassie Pope, S.George Hospital, London, UK)</li></ul><p>&nbsp;</p></div> Munich, Germany Diasorin diasorin@nomail.com Europe/Monaco public

All events